The risk of future Ebola outbreaks could be greatly reduced by more aggressive climate mitigation measures along with rapid progress on the Sustainable Development Goals, according to a new paper published in Nature Communications. Led by researchers at University College London, the article is the first study to examine the potential effects of global warming […] Continue reading ->
Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading ->
Trauma surgeon and veteran field worker, Christos Christou, has taken over the Médecins Sans Frontières (MSF) reins as International President, following his election by the organization’s International General Assembly last June. Christou, former president of the MSF Greece Board of Directors, will be faced with the leadership challenges of an organization that has grown from […] Continue reading ->
[US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading ->
[Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading ->